Ovid Therapeutics Inc (OVID) — Long-term Investment Intensity
Ovid Therapeutics Inc (OVID) has a Long-term Investment Intensity of 41.1% as of June 2026. Long-term investments of $95.24 Million represent 41.1% of total assets of $231.97 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Ovid Therapeutics Inc liquid asset ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Ovid Therapeutics Inc Long-term Investment Intensity (2021–2025)
This chart shows how Ovid Therapeutics Inc's Long-term Investment Intensity has evolved across 5 annual periods from 2021 to 2025. As of June 2026, the intensity stands at 41.1%, reflecting long-term investments of $95.24 Million against total assets of $231.97 Million USD. For the complete balance sheet picture, see OVID total assets.
Annual Long-term Investment Intensity for Ovid Therapeutics Inc (2021–2025)
The table below presents the year-by-year Long-term Investment Intensity for Ovid Therapeutics Inc from 2021 to 2025, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Ovid Therapeutics Inc (OVID) total liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 41.6% | $62.77 Million | $150.93 Million | ▲ +18.8 pp |
| 2024 | 22.8% | $20.97 Million | $92.17 Million | ▲ +10.5 pp |
| 2023 | 12.2% | $17.63 Million | $144.03 Million | ▲ +8.6 pp |
| 2022 | 3.6% | $5.62 Million | $155.27 Million | ▲ +2.8 pp |
| 2021 | 0.8% | $1.63 Million | $194.54 Million | — |